Abstract:Regenerative medicine through neural stem cells (NSCs) or neural progenitor cells (NPCs) has been proposed as an alterative avenue for restoring neurological dysfunction in amyotrophic lateral sclerosis (ALS). It is critical to understand the organization and distribution of endogenous adult NPCs in response to motor neuron degeneration before regenerative medicine can be applied for ALS therapy. For this reason, we analyzed the temporal response of NPCs to motor neuron degeneration in the spinal cord and brain using nestin enhancer-driven LacZ reporter transgenic mice (pNes-Tg mice, control) and bi-transgenic mice containing both the nestin enhancer-driven LacZ reporter gene and mutant G93A-SOD1 gene (Bi-Tg mice). We observed an increase of NPCs in the dorsal horns of the spinal cord at the disease onset and progression stages in the Bi-Tg mice compared with that of age-matched pNes-Tg control mice. In contrast, an increase of NPCs in the ventral horns was detected at the disease progression stage. On the other hand, an increase of NPCs in the motor cortex at the disease-onset stage, but not at the disease progression stage, was detected. Furthermore, a decrease of NPCs in the lateral ventricle at the disease progression stage was observed, whereas no difference in the number of NPCs in the hippocampus was detected at the disease onset and progression stages. Some of the NPCs differentiate into neuron-like cells in response to motor neuron degeneration. The organization and distribution of endogenous adult NPCs in the ALS-like transgenic mice at the disease onset and progression stages provide fundamental bases for consideration of regenerative therapy of ALS by increasing de novo neurogenesis.

Direct conversion of mouse astrocytes into neural progenitor cells and specific lineages of neurons

Reprogrammed Astrocytes As a Potential Therapy for Neurodegenerative Disorders.

Direct Reprogramming of Mouse Fibroblasts to Neural Progenitors

Direct Conversion of Dermal Fibroblasts into Neural Progenitor Cells by a Novel Cocktail of Defined Factors.

Direct Generation of Human Neuronal Cells from Adult Astrocytes by Small Molecules.

Reprogrammed Mouse Astrocytes Retain a “memory” of Tissue Origin and Possess More Tendencies for Neuronal Differentiation Than Reprogrammed Mouse Embryonic Fibroblasts

Conversion of Mouse Fibroblasts into Oligodendrocyte Progenitor-Like Cells Through a Chemical Approach.

Reprogrammed Astrocytes Display Higher Neurogenic Competence, Migration Ability and Cell Death Resistance Than Reprogrammed Fibroblasts

Direct Induction of Neural Progenitor Cells Transiently Passes Through a Partially Reprogrammed State

Direct Reprogramming of Fibroblasts into Neural Stem Cells by Single Non-Neural Progenitor Transcription Factor Ptf1a

Temporal response of neural progenitor cells to disease onset and progression in amyotrophic lateral sclerosis-like transgenic mice.

Reprogramming Astrocytes to Motor Neurons by Activation of Endogenous Ngn2 and Isl1

Pharmacological Reprogramming of Fibroblasts into Neural Stem Cells by Signaling-Directed Transcriptional Activation

Induced Neural Stem/precursor Cells for Fundamental Studies and Potential Application in Neurodegenerative Diseases

Myt1l induced direct reprogramming of pericytes into cholinergic neurons.

Selective Generation of Dopaminergic Precursors from Human Fibroblasts by Direct Lineage Conversion

Progress and Challenges of Cell Replacement Therapy for Neurodegenerative Diseases Based on Direct Neural Reprogramming

Characterization of Induced Neural Progenitors from Skin Fibroblasts by a Novel Combination of Defined Factors

Decoding single-cell molecular mechanisms in astrocyte-to-iN reprogramming via Ngn2- and Pax6-mediated direct lineage switching

Direct Reprogramming of Adult Human Fibroblasts to Functional Neurons under Defined Conditions.

Direct reprogramming of Sertoli cells into multipotent neural stem cells by defined factors